APA (7th ed.) Citation

Gholamreza Toogeh, Hassan Abolghasemi, Peyman Eshghi, Mohammadreza Managhchi, Mohammadreza Shaverdi-niasari, Katayoon Karimi, . . . Alireza Abdollahi. (2016). Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study). Iranian Society of Pathology.

Chicago Style (17th ed.) Citation

Gholamreza Toogeh, Hassan Abolghasemi, Peyman Eshghi, Mohammadreza Managhchi, Mohammadreza Shaverdi-niasari, Katayoon Karimi, Samin Roostaei, Neda Emran, and Alireza Abdollahi. Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study). Iranian Society of Pathology, 2016.

MLA (9th ed.) Citation

Gholamreza Toogeh, et al. Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study). Iranian Society of Pathology, 2016.